First Survey of Prostate Cancer Patients Identifies Health Care Gaps

Statistics from the World Health Organization (WHO) show that the average life expectancy of men with prostate cancer worldwide is still lower than that of women in the first investigation. Prostate cancer in men is the second most common type of cancer in the world and the seventh most common cancer in Egypt: in Egypt, more than 9.7% of the population is over 55 years old. Prostate, This proportion is expected to increase due to the aging of the population and the aging of society.

In order to fill the knowledge gap existing in the care of these patients, a number of specialists discussed the issue. The League of Arab States Patient Association is a way to strengthen the capacity of the health system to meet the needs of prostate cancer patients as well as the launch of the "All Important Voice Initiative" To support patients and all concerned. Opportunity to inform the Egyptian Association of Urology (Egypt) and the Egyptian Society of Cancer Patient Support (Cervaif (Egypt), Barbara Nassar (Lebanon) and the Lebanese Society (UAE), the Friends of Cancer Patients (UAE), the Saudi Cancer Society (Saudi Arabia) and the Saudi Society of Urology (Saudi Arabia)

During the first phase of the initiative, Ipsos (Independent Research Agency) will conduct a survey of prostate cancer patients in Egypt, Saudi Arabia, the United Arab Emirates and Lebanon to determine their needs.The results of the survey should be announced in November 2018. The second phase of the initiative will be followed by a joint cooperation in this area between the various stakeholders involved in various activities to meet the needs of the survey.

"Our main goal is to make conn Support cancer patients and provide the knowledge needed to support cancer patients We are very pleased to collaborate with Astelas Pharma, other patient organizations and medical associations in the region in all important initiatives. The cancer care system is a complex structure that involves many stakeholders: referring physicians, family members, patients, friends, patient organizations, government companies and pharmaceutical companies who often do not deal directly with the patient or cooperate with each other. . .